Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Should not be used alongside other GLP-1 receptor medications Gastric emptying may be delayed, requiring caution for procedures involving sedation or general anesthesia due to aspiration risk Use caution in those with a history of diabetic retinopathy 1-3 Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions Avoid use during pregnancy and breastfeeding 1 Enhances glucose-dependent insulin secretion Suppresses glucagon secretion Slows gastric emptying Influences brain regions involved in appetite regulation, leading to reduced hunger and caloric intake Improves insulin sensitivity 1-3 Supports weight loss Helps to minimize internal inflammation and improves cardiometabolic health measures 5 Q: How long does it take to see results

Because BPC-157 affects tissue regeneration, inflammation, and blood flow, it can be used to treat a wide variety of conditions, including: Gastric Ulcers Irritable Bowel Syndrome Tendon Injuries Ligament Injuries Joint Pain Erectile Dysfunction Because of the many benefits, BPC-157 therapy can also be used as a preventative treatment or performance booster
Tirzepatide is a dual-action metabolic therapy that supports weight control by improving insulin sensitivity, reducing appetite, and enhancing satiety
How often should I have these injections
Some users report improved recovery and energy levels, though these effects are less well-documented than the body composition benefits